{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:31:45Z","timestamp":1770507105415,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.mce.2015.06.010","type":"journal-article","created":{"date-parts":[[2015,6,25]],"date-time":"2015-06-25T03:43:11Z","timestamp":1435203791000},"page":"49-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Combination of DPP-4 inhibitor and PPAR\u03b3 agonist exerts protective effects on pancreatic \u03b2-cells in diabetic db\/db mice through the augmentation of IRS-2 expression"],"prefix":"10.1016","volume":"413","author":[{"given":"Hidenori","family":"Hirukawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kaneto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seizo","family":"Okauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Obata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumiko","family":"Hamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Tawaramoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Hashiramoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2015.06.010_bib1","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/db09-1694","article-title":"Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4","volume":"59","author":"Arakawa","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2015.06.010_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/628628","article-title":"Thiazolidinedione-induced fluid retention: recent insights into the molecular mechanisms","volume":"628628","author":"Beltowski","year":"2013","journal-title":"PPAR Res."},{"key":"10.1016\/j.mce.2015.06.010_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2006.08.015","article-title":"Beta-cell preservation with thiazolidinediones","volume":"76","author":"Campbell","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.mce.2015.06.010_bib4","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2337\/db05-1618","article-title":"ERK1\/2 control phosphorylation and protein level of cAMP-responsive element-binding protein: a key role in glucose-mediated pancreatic beta-cell survival","volume":"55","author":"Costes","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2015.06.010_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/1874467211104030187","article-title":"Roles and regulation of the transcription factor CREB in pancreatic beta -cells","volume":"4","author":"Dalle","year":"2011","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.mce.2015.06.010_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cmet.2010.04.007","article-title":"GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis","volume":"11","author":"De Marinis","year":"2010","journal-title":"Cell. Metab."},{"key":"10.1016\/j.mce.2015.06.010_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1152\/physiol.00032.2009","article-title":"Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes","volume":"24","author":"Donath","year":"2009","journal-title":"Physiol. (Bethesda)"},{"key":"10.1016\/j.mce.2015.06.010_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/dom.12005","article-title":"Vildagliptin preserves the mass and function of pancreatic beta cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes","volume":"15","author":"Hamamoto","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.mce.2015.06.010_bib9","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1172\/JCI18581","article-title":"Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes","volume":"112","author":"Hennige","year":"2003","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.mce.2015.06.010_bib10","doi-asserted-by":"crossref","first-page":"E278","DOI":"10.1152\/ajpendo.00388.2009","article-title":"Molecular mechanism by which pioglitazone preserves pancreatic beta-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARgamma agonist","volume":"298","author":"Kanda","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2015.06.010_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1507\/endocrj.K07E-041","article-title":"PDX-1 and MafA play a crucial role in pancreatic beta-cell differentiation and maintenance of mature beta-cell function","volume":"55","author":"Kaneto","year":"2008","journal-title":"Endocr. J."},{"key":"10.1016\/j.mce.2015.06.010_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00125-012-2776-x","article-title":"Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes","volume":"56","author":"Kang","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2015.06.010_bib13","doi-asserted-by":"crossref","first-page":"E510","DOI":"10.1152\/ajpendo.00128.2004","article-title":"Structural and functional analysis of pancreatic islets preserved by pioglitazone in db\/db mice","volume":"288","author":"Kawasaki","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2015.06.010_bib14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbrc.2010.12.021","article-title":"Effect of alogliptin, pioglitazone and glargine on pancreatic beta-cells in diabetic db\/db mice","volume":"404","author":"Kawashima","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2015.06.010_bib15","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.amjmed.2009.03.015","article-title":"Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use","volume":"122","author":"Kendall","year":"2009","journal-title":"Am. J. Med."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.mce.2015.06.010_bib16","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.2337\/diabetes.53.2007.S60","article-title":"Role of peroxisome proliferator-activated receptor-gamma in the glucose-sensing apparatus of liver and beta-cells","volume":"53","author":"Kim","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2015.06.010_bib17","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2337\/diabetes.49.9.1517","article-title":"Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter","volume":"49","author":"Kim","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2015.06.010_bib18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/diabetes.51.3.676","article-title":"Peroxisomal proliferator-activated receptor-gamma upregulates glucokinase gene expression in beta-cells","volume":"51","author":"Kim","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2015.06.010_bib19","doi-asserted-by":"crossref","first-page":"509437","DOI":"10.1155\/2012\/509437","article-title":"Endoplasmic reticulum stress and insulin biosynthesis: a review","volume":"2012","author":"Kim","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.mce.2015.06.010_bib20","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1128\/MCB.21.16.5624-5630.2001","article-title":"Preserved pancreatic beta-cell development and function in mice lacking the insulin receptor-related receptor","volume":"21","author":"Kitamura","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mce.2015.06.010_bib21","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.2337\/diabetes.49.11.1880","article-title":"Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia","volume":"49","author":"Kubota","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2015.06.010_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0092-8674(00)80546-2","article-title":"Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes","volume":"96","author":"Kulkarni","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.mce.2015.06.010_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/713609354","article-title":"Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV","volume":"40","author":"Lambeir","year":"2003","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.mce.2015.06.010_bib24","doi-asserted-by":"crossref","first-page":"966","DOI":"10.2337\/diabetes.51.4.966","article-title":"Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation","volume":"51","author":"Lingohr","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2015.06.010_bib25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejphar.2008.11.017","article-title":"The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob\/ob mice","volume":"602","author":"Moritoh","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.mce.2015.06.010_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1476-5381.2009.00145.x","article-title":"Combining a dipeptidyl peptidase-4 inhibitor, alogliptin, with pioglitazone improves glycaemic control, lipid profiles and beta-cell function in db\/db mice","volume":"157","author":"Moritoh","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mce.2015.06.010_bib27","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1074\/jbc.M508307200","article-title":"Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function","volume":"281","author":"Park","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2015.06.010_bib28","doi-asserted-by":"crossref","first-page":"10761","DOI":"10.1074\/jbc.275.15.10761","article-title":"Akt\/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein","volume":"275","author":"Pugazhenthi","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2015.06.010_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3858\/emm.2012.44.2.030","article-title":"Role of autophagy in diabetes and endoplasmic reticulum stress of pancreatic beta-cells","volume":"44","author":"Quan","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.mce.2015.06.010_bib30","doi-asserted-by":"crossref","first-page":"E681","DOI":"10.1152\/ajpendo.90931.2008","article-title":"High doses of dexamethasone induce increased beta-cell proliferation in pancreatic rat islets","volume":"296","author":"Rafacho","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.mce.2015.06.010_bib31","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.2337\/diabetes.53.2007.S119","article-title":"Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes","volume":"53","author":"Robertson","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2015.06.010_bib32","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00125-010-1955-x","article-title":"Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta cells","volume":"54","author":"Roger","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2015.06.010_bib33","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s00125-011-2069-9","article-title":"The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes","volume":"54","author":"Shimoda","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2015.06.010_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.2040-1124.2010.00044.x","article-title":"Combination treatment of db\/db mice with exendin-4 and gastrin preserves beta-cell mass by stimulating beta-cell growth and differentiation","volume":"1","author":"Tamaki","year":"2010","journal-title":"J.\u00a0Diabetes Investig."},{"key":"10.1016\/j.mce.2015.06.010_bib35","doi-asserted-by":"crossref","first-page":"516718","DOI":"10.1155\/2012\/516718","article-title":"A\u00a0simple matter of life and death-the trials of postnatal Beta-cell mass regulation","volume":"2012","author":"Tarabra","year":"2012","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.mce.2015.06.010_bib36","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1172\/JCI17645","article-title":"Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance","volume":"117","author":"Terauchi","year":"2007","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.mce.2015.06.010_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1463-1326.2011.01473.x","article-title":"Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence","volume":"14","author":"van Genugten","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.mce.2015.06.010_bib38","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/36116","article-title":"Disruption of IRS-2 causes type 2 diabetes in mice","volume":"391","author":"Withers","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.mce.2015.06.010_bib39","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2337\/db06-1033","article-title":"Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes","volume":"56","author":"Xu","year":"2007","journal-title":"Diabetes"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720715003202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720715003202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T12:57:18Z","timestamp":1537534638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720715003202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":39,"alternative-id":["S0303720715003202"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2015.06.010","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of DPP-4 inhibitor and PPAR\u03b3 agonist exerts protective effects on pancreatic \u03b2-cells in diabetic db\/db mice through the augmentation of IRS-2 expression","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2015.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}